Back
Voyager Therapeutics Vs. Bowman Consulting Group Industry Stock Comparison
Buy
59
VYGR
Voyager Therapeutics
Last Price:
8.49
Seasonality Move:
1.79%
Sell
24
BWMN
Bowman Consulting Group
Last Price:
31.00
Seasonality Move:
-0.83%
Buy
59
Voyager Therapeutics (VYGR)
is a Buy
Is Voyager Therapeutics a Buy, Sell or Hold?
- The current Voyager Therapeutics [VYGR] share price is $8.48. The Score for VYGR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- VYGR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
24
Bowman Consulting Group (BWMN)
is a Sell
Is Bowman Consulting Group a Buy, Sell or Hold?
- The current Bowman Consulting Group [BWMN] share price is $30.35. The Score for BWMN is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- BWMN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VYGR Stock Price Chart
What is Voyager Therapeutics's stock price today?
-
The Voyager Therapeutics share price today is $8.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VYGR is experiencing selling pressure, which indicates risk of future bearish movement.
BWMN Stock Price Chart
What is Bowman Consulting Group's stock price today?
-
The Bowman Consulting Group share price today is $30.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BWMN is experiencing selling pressure, which indicates risk of future bearish movement.
VYGR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 51.11 | Buy |
Chaikin Money Flow: | -297603 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.67 - 8.71) | Buy |
Bollinger Bands (100): | (7.57 - 9.33) | Buy |
BWMN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.51 | Sell |
Relative Strength Index (14 RSI): | 41.68 | Sell |
Chaikin Money Flow: | -60291 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.51 - 32.55) | Sell |
Bollinger Bands (100): | (30.77 - 36.53) | Sell |
VYGR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.62 | Sell |
20-day SMA: | 8.07 | Buy |
50-day SMA: | 8.81 | Sell |
200-day SMA: | 8.18 | Buy |
8-day EMA: | 8.47 | Buy |
20-day EMA: | 8.39 | Buy |
50-day EMA: | 8.47 | Buy |
200-day EMA: | 8.33 | Buy |
BWMN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.55 | Sell |
20-day SMA: | 31.45 | Sell |
50-day SMA: | 34 | Sell |
200-day SMA: | 31.53 | Sell |
8-day EMA: | 31.55 | Sell |
20-day EMA: | 31.89 | Sell |
50-day EMA: | 32.84 | Sell |
200-day EMA: | 31.59 | Sell |
Voyager Therapeutics Earnings Growth & VYGR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.14 per share, a decrease this year of $3.25 per share, and an increase next year of $0.04 per share.
Bowman Consulting Group Earnings Growth & BWMN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.46 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.66 per share, and an increase next year of $0.34 per share.
Voyager Therapeutics Technical Analysis
Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bowman Consulting Group Technical Analysis
Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |